Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

385
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
385
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of inflammation and senescence with azole compound C7 enables expansion of hematopoietic stem and progenitor cells.

Stem cells translational medicine·2026
Same author

Augmented intelligence: An emerging paradigm for AI in healthcare.

Annals of the Academy of Medicine, Singapore·2025
Same author

One-Year Tear Proteomic Alterations with Topical Cyclosporine-A 0.1% Emulsion in Patients with Allogeneic Stem Cell Transplant.

Transplantation and cellular therapy·2025
Same author

Cell and gene therapy approvals in Asia: regulatory landscape, access and affordability.

Cytotherapy·2025
Same author

Prognostic Value of Geriatric Characteristics in Allogeneic Haematopoietic Stem Cell Transplant Recipients Aged Over 60 Years.

EJHaem·2025
Same author

Tear Cytokine Changes up to One Year After Allogeneic Hematopoietic Stem Cell Transplant: Effect of Daily Topical Cyclosporine-A 0.1% Emulsion.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Aug 12, 2025

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.7K

Optimizing Blood Stem Cell Transplants Through Cellular Engineering.

Krystal Valerie Qian Ying Soh1,2, William Ying Khee Hwang1,3,4

  • 1National Cancer Centre Singapore, Singapore, SG 169610.

Blood Cell Therapy
|January 30, 2023
PubMed
Summary

Cellular engineering enhances hematopoietic stem cell transplants (HSCT) by expanding stem cells, selecting immune subsets, and adding regulatory or effector cells. These strategies aim to improve treatment for cancers and other diseases.

Keywords:
cell selection in haploidentical transplantationhaematopoietic stem and progenitor cell expansionhematopoietic stem cell transplantsimmune effector cell therapyimmune regulatory cells

More Related Videos

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

15.3K
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.2K

Related Experiment Videos

Last Updated: Aug 12, 2025

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.7K
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

15.3K
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.2K

Area of Science:

  • Hematology
  • Immunology
  • Cellular Engineering

Background:

  • Hematopoietic stem cell transplants (HSCT) are crucial for treating blood cancers, autoimmune disorders, and metabolic diseases.
  • Over 1.5 million HSCT procedures have been globally performed, highlighting their clinical significance.

Purpose of the Study:

  • To explore cellular engineering strategies for enhancing HSCT efficacy.
  • To improve outcomes by optimizing cell populations used in transplantation.

Main Methods:

  • Expanding hematopoietic stem and progenitor cells (HSPC) to increase cell numbers.
  • Implementing cellular subset selection to remove GvHD-causing cells and add anti-tumor/anti-viral immune cells.
  • Utilizing immune regulatory cells like mesenchymal stromal cells (MSC) and regulatory T cells (Tregs) to manage GvHD.
  • Employing immune effector cells for anti-tumor immunity, independent of or alongside HSCT.

Main Results:

  • Cellular engineering offers multiple avenues to augment HSCT effectiveness.
  • Strategies include cell expansion, targeted subset selection, and the addition of specific immune cell types.
  • These approaches aim to control GvHD, bolster anti-tumor immunity, and enhance anti-viral responses.

Conclusions:

  • Cellular engineering is a promising approach to refine HSCT protocols.
  • Optimizing cell composition and function can lead to improved patient outcomes in HSCT.
  • Further research in these areas holds potential for advancing the treatment of various hematological and immunological conditions.